These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 15018837)

  • 1. Effects of nicotinic stimulation on cognitive performance.
    Newhouse PA; Potter A; Singh A
    Curr Opin Pharmacol; 2004 Feb; 4(1):36-46. PubMed ID: 15018837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotine self-medication of cognitive-attentional processing.
    Evans DE; Drobes DJ
    Addict Biol; 2009 Jan; 14(1):32-42. PubMed ID: 18855804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of nicotine on Parkinson's disease.
    Kelton MC; Kahn HJ; Conrath CL; Newhouse PA
    Brain Cogn; 2000; 43(1-3):274-82. PubMed ID: 10857708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why do young women smoke? VI. A controlled study of nicotine effects on attention: pharmacogenetic interactions.
    Rigbi A; Yakir A; Sarner-Kanyas K; Pollak Y; Lerer B
    Pharmacogenomics J; 2011 Feb; 11(1):45-52. PubMed ID: 20231857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute nicotine improves cognitive deficits in young adults with attention-deficit/hyperactivity disorder.
    Potter AS; Newhouse PA
    Pharmacol Biochem Behav; 2008 Feb; 88(4):407-17. PubMed ID: 18022679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A review of the effects of nicotine on schizophrenia].
    Bidzan L
    Psychiatr Pol; 2007; 41(5):737-44. PubMed ID: 18421928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.
    Atzori G; Lemmonds CA; Kotler ML; Durcan MJ; Boyle J
    J Clin Psychopharmacol; 2008 Dec; 28(6):667-74. PubMed ID: 19011436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central nicotinic cholinergic systems: a role in the cognitive dysfunction in attention-deficit/hyperactivity disorder?
    Potter AS; Newhouse PA; Bucci DJ
    Behav Brain Res; 2006 Dec; 175(2):201-11. PubMed ID: 17081628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotinic acetylcholine receptor system and neuropsychiatric disorders.
    Singh A; Potter A; Newhouse P
    IDrugs; 2004 Dec; 7(12):1096-103. PubMed ID: 15599803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders.
    Sacco KA; Bannon KL; George TP
    J Psychopharmacol; 2004 Dec; 18(4):457-74. PubMed ID: 15582913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic nicotine interactions with clozapine and risperidone and attentional function in rats.
    Rezvani AH; Caldwell DP; Levin ED
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):190-7. PubMed ID: 16310917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of transdermal nicotine on attention in adult non-smokers with and without attentional deficits.
    Poltavski DV; Petros T
    Physiol Behav; 2006 Mar; 87(3):614-24. PubMed ID: 16466655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal nicotine exposure impairs nicotinic enhancement of central auditory processing and auditory learning in adult rats.
    Liang K; Poytress BS; Chen Y; Leslie FM; Weinberger NM; Metherate R
    Eur J Neurosci; 2006 Aug; 24(3):857-66. PubMed ID: 16848798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine and brain disorders.
    Mihailescu S; Drucker-Colín R
    Acta Pharmacol Sin; 2000 Feb; 21(2):97-104. PubMed ID: 11263271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal models of cognitive function.
    Decker MW
    Crit Rev Neurobiol; 1995; 9(4):321-43. PubMed ID: 8829849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of smoking and nicotine in neuropsychiatric disorders: evidence for therapeutic role of nicotinic acetylcholine receptors].
    Miyata H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Aug; 28(4):149-58. PubMed ID: 18800618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotinic actions on neuronal networks for cognition: general principles and long-term consequences.
    Poorthuis RB; Goriounova NA; Couey JJ; Mansvelder HD
    Biochem Pharmacol; 2009 Oct; 78(7):668-76. PubMed ID: 19426718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotinic systems in central nervous systems disease: degenerative disorders and beyond.
    Newhouse PA; Kelton M
    Pharm Acta Helv; 2000 Mar; 74(2-3):91-101. PubMed ID: 10812945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization.
    Levin ED; McClernon FJ; Rezvani AH
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):523-39. PubMed ID: 16220335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.